This APOE ɛ4−sex interaction might be moderated by estrogen because one study reported that females with the APOE ɛ4 allele who underwent estrogen replacement therapy had a reduced risk of Alzheimer’s disease (Rippon et al. This evidence concerns the gene APOE and Alzheimer disease.